CTCFL and cancer: BORIS silencing in colorectal cancer cells highly expressing BORIS strongly suppressed cancer cell growth compared with that in colorectal cancer cells with low BORIS expression, suggesting the potential of BORIS knockdown for treatment of colorectal cancer with high expression of BORIS.